Feb. 25, 2025 – The FDA has approved a new treatment plan for a long-acting injection, making it easier for people with moderate to severe opioid use disorder (OUD) to start and keep up with ...

RCMP discovered the drug during a search they conducted in the Amherst area in December while investigating the theft of a ...

These were defined risks on the label and although we feel terrible ... all of which say they too paid a price in the opioid epidemic. "It felt like every major company under the sun was coming ...

The FDA approved label changes that include a rapid initiation protocol and alternative injection sites. The changes aim to shorten the time to achieve treatment effects in patients with opioid ...

Indivior said the U.S. Food and Drug Administration approved label changes for its opioid-dependence treatment Sublocade, including a rapid initiation protocol and alternative injection sites.